Synamics Therapeutics

At Synamics Therapeutics, our mission is crystal clear: we harness advanced computational and AI/ML techniques to profoundly impact patients' lives. As an end-to-end drug discovery company, we're dedicated to revolutionizing intractable cancer care through AI-powered adaptive drug design. Our interdisciplinary team uncovers disease mechanisms, identifies unique therapeutic targets, and customizes treatments based on individual molecular profiles. We're driven by a deep commitment to redefine healthcare through next-generation precision medicine and AI-driven drug discovery. Beyond genomics, we employ a versatile approach to dissect proteins and biological networks. At Synamics, we firmly believe that the future of medicine is not one-size-fits-all but tailored, adaptive, and precise.

Synamics Therapeutics headquartered in Europe, operates in the Biotechnology, Life Science, Pharmaceutical, Therapeutics sector. With a team of 11-50 employees, Synamics Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Pre Seed Round - Synamics Therapeutics, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.